Bloomberg: Supreme Court Declines to Consider Medical Diagnostic Patents

一月 13, 2020

O’Melveny partner and Life Sciences Litigation head Lisa Pensabene is quoted in this Bloomberg article about the US Supreme Court’s decision to stay out of the debate over what types of medical diagnostic tests can be patented. “It’s important, not just to us nerdy patent practitioners, but to patients and to the medical industry,” Pensabene said. “Diagnostics are critical in identifying and characterizing the type of disease. We’re treating patients now in a much more nuanced way than in years past. Think of a scalpel rather than a sledgehammer.”